Skip to content

Russia approves trial of AstraZeneca COVID-19 vaccine

August 21, 2020

AstraZeneca (AZN.L) has received regulatory approval to conduct part of a Phase III trial of its potential COVID-19 vaccine, AZD1222, in Russia, a filing in the Russian registry of clinical trials showed on Friday.

The trial will involve 150 participants and will be handled by four medical facilities in St. Petersburg and Moscow, the registry filing, dated Friday, showed.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: